Lycia Therapeutics
LYCA31.9402.71% ( -0.890 )
交易中: 11月13日 10:13:36 (美东)股东
全部股东
股东类型
- 公众及其他48.11%
- 风投/私募22.94%
- 对冲基金13.53%
- 机构投资者10.55%
- 其他4.87%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
Versant Venture Management, LLC | 12.18% | 702.53 万 | -- | +702.53 万 | |
VR Management, LLC | 10.76% | 620.68 万 | -- | +620.68 万 | |
Redmile Group, LLC | 7.22% | 416.49 万 | -- | +416.49 万 | |
RTW Investments, LP | 6.31% | 363.94 万 | -- | +363.94 万 | |
Janus Henderson Group Ltd. | 6.03% | 347.62 万 | -- | +347.62 万 | |
Blue Owl Credit Private Fund Advisors LLC | 3.39% | 195.56 万 | -- | +195.56 万 | |
Eli Lilly and Company | 1.91% | 110.46 万 | -- | +110.46 万 | |
Carolyn BertozziFounder & Chair of Scientific Advisory Board | 1.57% | 90.48 万 | -- | +90.48 万 | |
Venrock Management, LLC | 1.13% | 65.18 万 | -- | +65.18 万 | |
Aetna TrombleyCEO, Secretary, President & Director | 0.72% | 41.53 万 | -- | +41.53 万 | |
Clare OzawaFormer Independent Director | 0.36% | 20.52 万 | -- | +20.52 万 | |
William RieflinIndependent Chair of the Board | 0.16% | 8.98 万 | -- | +8.98 万 | |
Steven StabenChief Scientific Officer | 0.10% | 5.54 万 | -- | +5.54 万 | |
Laurent FischerIndependent Director | 0.06% | 3.33 万 | -- | +3.33 万 | |
Chin Hyok LeeChief Medical Officer | 0.00% | 0.00 | -- | +0 | |
Jane Pritchett HendersonIndependent Director | 0.00% | 0.00 | -- | +0 |